After surgery and radioiodine (RAI) therapy, monitoring of most patients with DTC is based on serum tumor markers (thyroglobulin and thyroglobulin antibodies) and neck ultrasound, with additional imaging required when a disease spread is suspected [42]. This evidence concerns the gene TG and neoplasm.